Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19167224rdf:typepubmed:Citationlld:pubmed
pubmed-article:19167224lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:19167224lifeskim:mentionsumls-concept:C0011168lld:lifeskim
pubmed-article:19167224lifeskim:mentionsumls-concept:C0027126lld:lifeskim
pubmed-article:19167224lifeskim:mentionsumls-concept:C0547040lld:lifeskim
pubmed-article:19167224pubmed:issue3lld:pubmed
pubmed-article:19167224pubmed:dateCreated2009-3-16lld:pubmed
pubmed-article:19167224pubmed:abstractTextThe phenotype of myotonic dystrophy type 2 (DM2) shows similarities as well as differences to that of myotonic dystrophy type 1 (DM1). Dysphagia, a predominant feature in DM1, has not yet been examined in DM2. In a recent nationwide questionnaire survey of gastrointestinal symptoms in DM2, 12 out of 29 DM2 patients reported to have difficulty in swallowing for solid food. The aim of the study was to investigate the presence of dysphagia in patients with genetically proven DM2 who reported difficulty in swallowing for solid food at the questionnaire survey. Swallowing function and fiberoptic endoscopic evaluation of swallowing (FEES) were examined by a speech therapist and otorhinolaryngologist, respectively. In DM2 patients who reported difficulty in swallowing the presence of dysphagia could be confirmed (clinically in 100%, by FEES in 88%). A correlation exists between Dysphagia Outcome and Severity Score (DOSS) and age (p=0.05). None of the patients was underweight, and none of the patients had suffered aspiration pneumonia in the past. Dysphagia is present among DM2 patients and is more severe in older patients. However, dysphagia is generally mild, and do not lead to weight loss, or aspiration pneumonia.lld:pubmed
pubmed-article:19167224pubmed:languageenglld:pubmed
pubmed-article:19167224pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19167224pubmed:citationSubsetIMlld:pubmed
pubmed-article:19167224pubmed:statusMEDLINElld:pubmed
pubmed-article:19167224pubmed:monthMarlld:pubmed
pubmed-article:19167224pubmed:issn1873-2364lld:pubmed
pubmed-article:19167224pubmed:authorpubmed-author:van VlietJJlld:pubmed
pubmed-article:19167224pubmed:authorpubmed-author:EnsinkRRlld:pubmed
pubmed-article:19167224pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:19167224pubmed:authorpubmed-author:de SwartB J...lld:pubmed
pubmed-article:19167224pubmed:authorpubmed-author:KnuijtSSlld:pubmed
pubmed-article:19167224pubmed:authorpubmed-author:TielemanA AAAlld:pubmed
pubmed-article:19167224pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19167224pubmed:volume19lld:pubmed
pubmed-article:19167224pubmed:ownerNLMlld:pubmed
pubmed-article:19167224pubmed:authorsCompleteYlld:pubmed
pubmed-article:19167224pubmed:pagination196-8lld:pubmed
pubmed-article:19167224pubmed:meshHeadingpubmed-meshheading:19167224...lld:pubmed
pubmed-article:19167224pubmed:meshHeadingpubmed-meshheading:19167224...lld:pubmed
pubmed-article:19167224pubmed:meshHeadingpubmed-meshheading:19167224...lld:pubmed
pubmed-article:19167224pubmed:meshHeadingpubmed-meshheading:19167224...lld:pubmed
pubmed-article:19167224pubmed:meshHeadingpubmed-meshheading:19167224...lld:pubmed
pubmed-article:19167224pubmed:meshHeadingpubmed-meshheading:19167224...lld:pubmed
pubmed-article:19167224pubmed:meshHeadingpubmed-meshheading:19167224...lld:pubmed
pubmed-article:19167224pubmed:meshHeadingpubmed-meshheading:19167224...lld:pubmed
pubmed-article:19167224pubmed:meshHeadingpubmed-meshheading:19167224...lld:pubmed
pubmed-article:19167224pubmed:meshHeadingpubmed-meshheading:19167224...lld:pubmed
pubmed-article:19167224pubmed:meshHeadingpubmed-meshheading:19167224...lld:pubmed
pubmed-article:19167224pubmed:meshHeadingpubmed-meshheading:19167224...lld:pubmed
pubmed-article:19167224pubmed:meshHeadingpubmed-meshheading:19167224...lld:pubmed
pubmed-article:19167224pubmed:meshHeadingpubmed-meshheading:19167224...lld:pubmed
pubmed-article:19167224pubmed:meshHeadingpubmed-meshheading:19167224...lld:pubmed
pubmed-article:19167224pubmed:meshHeadingpubmed-meshheading:19167224...lld:pubmed
pubmed-article:19167224pubmed:meshHeadingpubmed-meshheading:19167224...lld:pubmed
pubmed-article:19167224pubmed:meshHeadingpubmed-meshheading:19167224...lld:pubmed
pubmed-article:19167224pubmed:meshHeadingpubmed-meshheading:19167224...lld:pubmed
pubmed-article:19167224pubmed:year2009lld:pubmed
pubmed-article:19167224pubmed:articleTitleDysphagia is present but mild in myotonic dystrophy type 2.lld:pubmed
pubmed-article:19167224pubmed:affiliationNeuromuscular Center Nijmegen, Department of Neurology, Radboud University, Nijmegen Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. a.tieleman@neuro.umcn.nllld:pubmed
pubmed-article:19167224pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19167224pubmed:publicationTypeCase Reportslld:pubmed